The stock finished 50.41% below its 52-week high of $113.84 reached on 3 June, while trading volume rose to 3.6 million from a 50-day average of 3.2 million.
As the insurance market softens, is Brown & Brown's stock plunge a unique failure or a canary in the coal mine?
With organic growth flat, is Brown & Brown's acquisition strategy a sustainable path or a high-stakes gamble for investors?